Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 848

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 848
---
 upon completion of the merger, all warrants of the Company were converted into warrants to purchase Kintara common stock. All outstanding shares of the Company’s Preferred Stock were converted into 16,912,843shares of common stock. As of December 31, 2024, the Company had two classes of stock defined in its Amended and Restated Articles of Incorporation (the “Articles). Common Stock -The Company is authorized to issue up to 75,000,000shares of Common Stock based on the Articles. Holders of common stock are entitled to one vote for each share of common stock. As of December 31, 2024, there were 42,323,759shares of common stock outstanding, of which 4,730are unregistered shares of warrants exercised after the merger. Preferred Stock -The Company is authorized to issue up to 5,000,000shares of Preferred Stock based on the Articles. The historical Kineta Series A Preferred Stock were assumed from the merger and outstanding and have a stated value of $ 278,530as of December 31, 2024. Warrants -The following table summarizes the Company’s outstanding common stock warrants as of December 31, 2024. F-88

TUHURA BIOSCIENCES, INC AND SUBSIDIARIES Notes to the consolidated financial statements For the years ended December 31, 2024, and 2023

|                                                        |     | Outstanding |            |     | Weightedaverageexercise price |          |     | Expiration dates           |
|:-------------------------------------------------------|:----|:------------|-----------:|:----|:------------------------------|---------:|:----|:---------------------------|
| Historical TuHURA common stock warrants                |     |             | 10,592,387 |     | $                             |     4.16 |     | February 2025toAugust 2029 |
| Historical Kintara common stock warrants               |     |             |     17,468 |     | $                             | 1,362.41 |     | March 2025toApril 2027     |
| 2024 common stock warrants issued to financial advisor |     |             |    297,029 |     | $                             |     0.01 |     | April 2027                 |

Warrant modification

In August 2024, the Company extended the exercise period of its common stock purchase warrants issued in connection with Legacy TuHURA Series A Preferred Stock (